Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gabriel Weber is active.

Publication


Featured researches published by Gabriel Weber.


Clinical Infectious Diseases | 2000

An Outbreak of Streptococcus pneumoniae Serotype 1 in a Closed Community in Southern Israel

Ron Dagan; Serge Gradstein; Ilana Belmaker; Nurith Porat; Yaffa Siton; Gabriel Weber; Jacob Janco; Pablo Yagupsky

An outbreak of Streptococcus pneumoniae serotype 1 occurred in a closed community that was characterized by poverty and crowding. Vaccine was administered to individuals aged >2 years; no new cases occurred among vaccine recipients. Six weeks after vaccination, carriage of serotype 1, but not of other serotypes, decreased 8.8-fold. This suggests that the reduction in serotype 1 carriage reflects the natural course of the outbreak rather than a vaccine effect. Polysaccharide vaccine may be helpful in terminating pneumococcal outbreaks but may not affect pneumococcal carriage.


Infection Control and Hospital Epidemiology | 2007

Meningitis following spinal anesthesia: 6 cases in 5 years.

Lisa Rubin; Hannah Sprecher; Ahmed Kabaha; Gabriel Weber; Nava Teitler; Shmuel Rishpon

We describe 6 cases of meningitis after spinal anesthesia associated with a single anesthesiologist over the course of 5 years. The earliest case occurred in 2000, and the other 5 cases occurred over the course of 14 months in 2004-2005. The case identified in 2000 was culture-positive for Streptococcus salivarius. The other 5 cases were culture-negative for this organism but in 2 cases, the cerebrospinal fluid was found to be positive for bacterial DNA that was identified as belonging to S. salivarius by sequencing of the 16S rRNA gene. The association with a single anesthesiologist and a single hospital during a relatively short interval, however, lead us to believe that these occurrences are part of a series associated with possible violations of aseptic technique.


Journal of Infection | 1999

Massive pumonary haemorrhage caused by leptospirosis successfully treated with nitric oxide inhalation and haemofiltration

Abraham Borer; I. Metz; Jacob Gilad; Klaris Riesenberg; N. Weksler; Gabriel Weber; Michael Alkan; Jacob Horowitz

A patient with leptospirosis who developed oliguric renal failure, massive pulmonary haemorrhage and respiratory failure is described. The patients clinical condition and arterial oxygenation failed to improve despite vigorous supportive measures. Nitric oxide inhalation and haemofiltration resulted in a marked clinical improvement and subsequent full recovery. We suggest that the addition of haemofiltration and nitric oxide inhalation therapy should be considered in patients with pulmonary haemorrhage and renal failure caused by leptospirosis, in whom conventional therapy fails.


Clinical Infectious Diseases | 2007

Acremonium Vertebral Osteomyelitis: Molecular Diagnosis and Response to Voriconazole

Yoav Keynan; Hannah Sprecher; Gabriel Weber

We present a case of Acremonium vertebral osteomyelitis that relapsed despite surgical debridement and prolonged treatment with liposomal amphotericin B, but which responded to voriconazole therapy. The report highlights the role of molecular diagnosis of rare fungal osteomyelitis. The patient was successfully treated with voriconazole.


American Journal of Cardiology | 2000

Incidence and clinical significance of bacteremia and sepsis among cardiac patients treated with intra-aortic balloon counterpulsation pump

Eugene Crystal; Abraham Borer; Jacob Gilad; Irena Haick; Gabriel Weber; Michael Alkan; Klaris Riesenberg; Francisc Schlaeffer; Alexander Battler; Reuben Ilia; Harel Gilutz; Johnathan Leor

In this prospective study, a significant incidence of fever (47%), true bacteremia (15%), and sepsis (12%), were found in 60 cardiac patients treated with an intra-aortic balloon counterpulsation pump. The benefit of antibiotic prophylaxis in this setting should therefore be evaluated.


Scandinavian Journal of Infectious Diseases | 1997

Pleural Empyema Caused by Leuconostoc spp.

Abraham Borer; Gabriel Weber; Lone S. Avnon; Klaris Riesenberg; Michael Alkan

A rare case of pleural empyema caused by Leuconostoc spp. is reported. The patient was treated successfully with clindamycin. To our knowledge this is the first reported case of pleural empyema caused by Leuconostoc spp. In a patient with characteristic predisposing factors, such as a serious underlying disease, previous vancomycin therapy and thoracic access device. Our case illustrates that Leuconostoc spp. can cause pleural infection as further evidence of its human pathogenicity.


European Journal of Clinical Microbiology & Infectious Diseases | 1999

Infective endocarditis due to Fusobacterium nucleatum in an intravenous drug abuser.

Gabriel Weber; Abraham Borer; Klaris Riesenberg; F. Schlaeffer

Abstract Infective endocarditis due to anaerobic non-spore-forming gram-negative bacilli in intravenous drug abusers is exceedingly rare, with only two cases being previously reported in the literature. A case of endocarditis due to Fusobacterium nucleatum in an intravenous drug abuser is reported, accompanied by a review of the literature.


PLOS ONE | 2014

Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel

Gili Regev-Yochay; Galia Rahav; Klaris Riesenberg; Yonit Wiener-Well; Jacob Strahilevitz; Michal Stein; Daniel Glikman; Gabriel Weber; Israel Potasman; Ron Dagan

Background PCV7 was introduced as universal childhood vaccination in Israel in July 2009 and PCV13 in November 2010. Here we report data on adult invasive pneumococcal disease (IPD), two years post PCV7 implementation and before an expected effect of PCV13. Methods An ongoing nationwide active-surveillance (all 27 laboratories performing blood cultures in Israel), providing all blood & CSF S. pneumoniae isolates from persons >18 y was initiated in July 2009. Capture-recapture method assured reporting of >95% cases. All isolates were serotyped in one central laboratory. IPD outcome and medical history were recorded in 90%. Second year post PCV implementation is compared to the first year. Results During July 2009 to June 2011, 970 IPD cases were reported (annual incidence [/100,000] of 9.17 and 10.16 in the two consecutive years, respectively). Respective case fatality rates (CFRs) were 20% and 19.1%. Incidence of IPD and CFR increased with age and number of comorbidities. Incidence rate was significantly greater during the second winter, 7.79/100,000 vs. 6.14/100,000 in first winter, p = 0.004, with a non-significant decrease during summer months (3.02 to 2.48/100,000). The proportion of IPD cases due to PCV7-serotypes decreased from 27.5% to 13.1% (first to second year) (p<0.001). Yet, non-PCV13-strains increased from 32.7% to 40.2% (p = 0.017). The increase in non-PCV13-strains was highly significant in immunocompromised patients and to a lesser degree in non-immunocompromised at risk or in older patients (>64 y). Among younger/healthier patients serotype 5 was the major increasing serotype. Penicillin and ceftriaxone resistance decreased significantly in the second year. Conclusions While overall annual incidence of IPD did not change, the indirect effect of PCV7 vaccination was evident by the significant decrease in PCV7 serotypes across all age groups. Increase in non-VT13 strains was significant in immunocompromised patients. A longer follow-up is required to appreciate the full effect of infant vaccination on annual IPD.


Clinical Rheumatology | 1997

Septic arthritis due to bacteroides fragilis after pilonidal sinus resection in a patient with rheumatoid arthritis.

Abraham Borer; Gabriel Weber; Klaris Riesenberg; F. Schlaeffer; J. Horowitz

SummaryBacteroides fragilis is a rare cause of septic arthritis. Most patients with B.fragilis septic arthritis have a chronic joint disease, particularly rheumatoid arthritis, and sources of infection are lesions of the gastrointestinal tract and the skin. We report a 69-year-old male, who developed B.fragilis septic arthritis after pilonidal sinus resection. High level of suspicion of development B.fragilis septic arthritis must be present in patients with chronic joint disease in whom gastrointestinal or skin surgery was previously performed.


Journal of Travel Medicine | 1998

Schistosomiasis Presenting as Acute Appendicitis in a Traveler

Gabriel Weber; Abraham Borer; Howard J. Zirkin; Klaris Riesenberg; Michael Alkan

Collaboration


Dive into the Gabriel Weber's collaboration.

Top Co-Authors

Avatar

Klaris Riesenberg

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Abraham Borer

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Hannah Sprecher

Technion – Israel Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Michael Alkan

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Ron Dagan

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar

Daniel Glikman

Western Galilee Hospital

View shared research outputs
Top Co-Authors

Avatar

F. Schlaeffer

Ben-Gurion University of the Negev

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Israel Potasman

Rappaport Faculty of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge